Corrigendum to "Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase" [Antivir. Res. 218 (2023) 105716-105728, doi: 10.1016/j.antiviral.2023.105716]

Antiviral Res. 2023 Nov:219:105729. doi: 10.1016/j.antiviral.2023.105729. Epub 2023 Sep 28.
No abstract available

Publication types

  • Published Erratum